Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms GT-19506, GT19506 |
Target |
Action inhibitors |
Mechanism MYC inhibitors(Myc proto-oncogene protein inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Small Cell Lung Cancer | Preclinical | United States | 01 Jul 2021 | |
Hematologic Neoplasms | Preclinical | United States | 01 Jul 2021 |